Differences in guidelines from the UK and USA unexpectedly generate inadequate screening recommendations for second-degree relatives of patients with colorectal cancer in the UK, finds this month's issue of Colorectal Disease.
This month's American Journal of Gastroenterology examined the individual contribution of psychosocial risk factors, demographic factors, somatic symptoms, and gastrointestinal infection within a non-clinical, IBS-free population before infection occurred.
October's publication of the Alimentary Pharmacology & Therapeutics examines the validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhea-predominant irritable bowel syndrome.
The latest issue of the Annals of Internal Medicine investigates long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus.
October's issue of the Alimentary Pharmacology & Therapeutics identifies prognostic factors for real-life long-term efficacy of infliximab in Crohn's disease.
A study reported in this month's American Journal of Gastroenterology conducts a nationwide population-based study to reveal the cancer risk in patients with IBD.
Chronic hepatitis B is associated with higher inpatient resource utilization and mortality versus chronic hepatitis C, reports this month's issue of the Digestive Diseases & Sciences.
Hep C virus core antigen assays with signal amplification have high sensitivity, high specificity, and good correlation with HCV RNA levels, reports this month's Annals of Internal Medicine.
The most recent issue of the Journal of Crohn's & Colitis evaluated the impact of eHealth technologies on conventional clinical indices and patient-reported outcome measures in IBD.
A study in September's issue of the American Journal of Gastroenterology prospectively validates a predictive overbooking model to prevent endoscopy clinic no-shows.
The most recent issue of the International Journal of Colorectal Disease elucidated the role of preoperative inflammation on postoperative infectious complications and to understand if, through biological markers, it is possible to identify preoperatively patients at higher risk of infection.
The most recent issue of the American Journal of Gastroenterology examines the clinical benefits and limitations of esophageal impedance monitoring, and provides clinical pearls and pitfalls associated with this technology
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .